Shuttle Pharmaceuticals Holdings (SHPH) Operating Expenses (2021 - 2026)
Shuttle Pharmaceuticals Holdings (SHPH) posted quarterly Operating Expenses of $2.2 million for Q1 2026, down 24.89% year-over-year from $3.0 million in Q1 2025, and down 36.66% quarter-over-quarter from $3.5 million in Q4 2025.
Shuttle Pharmaceuticals Holdings (SHPH) Operating Expenses (2021 - 2026) Analysis & Trends
Shuttle Pharmaceuticals Holdings' Operating Expenses history runs 6 years deep, the most recent figure standing at $2.2 million for Q1 2026.
- In Q1 2026, Operating Expenses fell 24.89% year-over-year to $2.2 million; the TTM figure through Mar 2026 stood at $11.9 million (up 28.41% YoY), while the FY2025 annual figure was $11.9 million, up 54.84% from the prior year.
- Operating Expenses for Q1 2026 stood at $2.2 million, down from $3.5 million in the prior quarter.
- The five-year high for Operating Expenses was $3.9 million in Q2 2025, with the low at $353626.0 in Q2 2022.
- The 5-year median for Operating Expenses is $1.5 million (2023), against an average of $1.8 million.
- The sharpest annual moves came in 2022 and 2023: Operating Expenses slumped 46.35% in 2022, then surged 314.46% in 2023.
- Shuttle Pharmaceuticals Holdings' Operating Expenses stood at $530336.0 in 2022, then soared by 141.89% to $1.3 million in 2023, then surged by 38.53% to $1.8 million in 2024, then jumped by 96.95% to $3.5 million in 2025, then sank by 36.66% to $2.2 million in 2026.
- Business Quant data shows SHPH's Operating Expenses at $2.2 million in Q1 2026, $3.5 million in Q4 2025, and $2.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn | 1.29 Bn |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn | 215.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -2.85 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 452.50 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 1.45 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 807.50 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 550.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Shuttle Pharmaceuticals Holdings | 1.91 Mn | 1.91 Mn | - | 2.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.22 Mn |
| Dec 31, 2025 | 3.50 Mn |
| Sep 30, 2025 | 2.27 Mn |
| Jun 30, 2025 | 3.91 Mn |
| Mar 31, 2025 | 2.95 Mn |
| Dec 31, 2024 | 1.78 Mn |
| Sep 30, 2024 | 3.05 Mn |
| Jun 30, 2024 | 1.48 Mn |
| Mar 31, 2024 | 1.38 Mn |
| Dec 31, 2023 | 1.28 Mn |
| Sep 30, 2023 | 1.60 Mn |
| Jun 30, 2023 | 1.47 Mn |
| Mar 31, 2023 | 1.54 Mn |
| Dec 31, 2022 | 530,336.00 |
| Sep 30, 2022 | 821,468.00 |
| Jun 30, 2022 | 353,626.00 |
| Mar 31, 2022 | 638,396.00 |
| Dec 31, 2021 | 988,539.00 |
| Sep 30, 2021 | 242,116.00 |